Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/125904
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Campo DC Valor Lengua/Idioma
dc.contributor.authorValiente-Alandi, Íñigo-
dc.contributor.authorAlbo, Carmen-
dc.contributor.authorHerrero, Diego-
dc.contributor.authorArza, Elvira-
dc.contributor.authorGarcía-Gómez, María-
dc.contributor.authorSegovia, José Carlos-
dc.contributor.authorCapecchi, Mario-
dc.contributor.authorBernad, Antonio-
dc.date.accessioned2015-11-25T17:56:37Z-
dc.date.available2015-11-25T17:56:37Z-
dc.date.issued2015-10-26-
dc.identifier.citationStem Cell Research & Therapy 6(1): 205 (2015)-
dc.identifier.issn1757-6512-
dc.identifier.urihttp://hdl.handle.net/10261/125904-
dc.description.abstract[Introduction] The mammalian adult heart maintains a continuous, low cardiomyocyte turnover rate throughout life. Although many cardiac stem cell populations have been studied, the natural source for homeostatic repair has not yet been defined. The Polycomb protein BMI1 is the most representative marker of mouse adult stem cell systems. We have evaluated the relevance and role of cardiac Bmi1 + cells in cardiac physiological homeostasis.-
dc.description.abstract[Methods] Bmi1 CreER/+;Rosa26 YFP/+ (Bmi1-YFP) mice were used for lineage tracing strategy. After tamoxifen (TM) induction, yellow fluorescent protein (YFP) is expressed under the control of Rosa26 regulatory sequences in Bmi1 + cells. These cells and their progeny were tracked by FACS, immunofluorescence and RT-qPCR techniques from 5 days to 1 year.-
dc.description.abstract[Results] FACS analysis of non-cardiomyocyte compartment from TM-induced Bmi1-YFP mice showed a Bmi1 +-expressing cardiac progenitor cell (Bmi1-CPC: B-CPC) population, SCA-1 antigen-positive (95.9 ± 0.4 %) that expresses some stemness-associated genes. B-CPC were also able to differentiate in vitro to the three main cardiac lineages. Pulse-chase analysis showed that B-CPC remained quite stable for extended periods (up to 1 year), which suggests that this Bmi1 + population contains cardiac progenitors with substantial self-maintenance potential. Specific immunostaining of Bmi1-YFP hearts serial sections 5 days post-TM induction indicated broad distribution of B-CPC, which were detected in variably sized clusters, although no YFP+ cardiomyocytes (CM) were detected at this time. Between 2 to 12 months after TM induction, YFP+ CM were clearly identified (3 ± 0.6 % to 6.7 ± 1.3 %) by immunohistochemistry of serial sections and by flow cytometry of total freshly isolated CM. B-CPC also contributed to endothelial and smooth muscle (SM) lineages in vivo.-
dc.description.abstract[Conclusions] High Bmi1 expression identifies a non-cardiomyocyte resident cardiac population (B-CPC) that contributes to the main lineages of the heart in vitro and in vivo.-
dc.description.sponsorshipThis study was supported by grants to A.B. from the Ministry of Science and Innovation (SAF2012-34327; PLE2009-0147 and PSE-010000-2009-3), the Research Program of the Comunidad Autónoma de Madrid (S2010/BMD-2420), the Instituto de Salud Carlos III (RETICS-RD12/0019/0018 and RETICS-RD12/0019/0023) and the European Commission (Proposal 242038). The CNB-CSIC and CNIC are supported by the Spanish Ministry of Economy and Competitiveness.-
dc.publisherBioMed Central-
dc.relation.isversionofPublisher's version-
dc.rightsopenAccess-
dc.titleCardiac Bmi1 + cells contribute to myocardial renewal in the murine adult heart-
dc.typeartículo-
dc.identifier.doi10.1186/s13287-015-0196-9-
dc.relation.publisherversionhttp://dx.doi.org/10.1186/s13287-015-0196-9-
dc.date.updated2015-11-25T17:56:37Z-
dc.language.rfc3066en-
dc.rights.holderValiente-Alandi et al.-
dc.rights.licensehttp://creativecommons.org/licenses/by/4.0/-
dc.contributor.funderMinisterio de Ciencia e Innovación (España)-
dc.contributor.funderComunidad de Madrid-
dc.contributor.funderInstituto de Salud Carlos III-
dc.contributor.funderEuropean Commission-
dc.relation.csic-
dc.identifier.funderhttp://dx.doi.org/10.13039/501100004837es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100004587es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100000780es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/100012818es_ES
dc.identifier.pmid26503423-
dc.type.coarhttp://purl.org/coar/resource_type/c_6501es_ES
item.openairetypeartículo-
item.grantfulltextopen-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextWith Fulltext-
Aparece en las colecciones: (CNB) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
13287_2015_Article_196.pdf3,82 MBAdobe PDFVista previa
Visualizar/Abrir
Show simple item record

CORE Recommender

PubMed Central
Citations

22
checked on 01-abr-2024

SCOPUSTM   
Citations

36
checked on 15-abr-2024

WEB OF SCIENCETM
Citations

33
checked on 25-feb-2024

Page view(s)

323
checked on 18-abr-2024

Download(s)

246
checked on 18-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


Este item está licenciado bajo una Licencia Creative Commons Creative Commons